insights_auto
Kwa nini ORX imepungua kwa 16.73%?
Fahamu zaidichevron_right
ORX:STO
Orexo AB
SEKÂ 0.87
arrow_downward
-16.73%(-0.17) Siku 1
12 Nov, 17:29:50 GMT +1 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ORX...
Fungua
SEKÂ 1.04
Juu
SEKÂ 1.05
Chini
SEKÂ 0.80
Mtaji wa soko
304.20M
Wastani wa kiasi cha mauzo
elfu 613.79
Kiasi cha mauzo ya hisa
3.83M
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.04
Juu kwa wiki 52
SEKÂ 22.55
Chini kwa wiki 52
SEKÂ 0.80
EPS
SEKÂ 21.73
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Fungua
SEKÂ 1.04
Juu
SEKÂ 1.05
Chini
SEKÂ 0.80
Mtaji wa soko
304.20M
Wastani wa kiasi cha mauzo
elfu 613.79
Kiasi cha mauzo ya hisa
3.83M
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.04
Juu kwa wiki 52
SEKÂ 22.55
Chini kwa wiki 52
SEKÂ 0.80
EPS
SEKÂ 21.73
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingView
·
saa 1 iliyopita
Dow, S&P 500, Nasdaq Futures Edge Higher As Markets Attempt To Recover From Nvidia Rout: SLS, MSFT, CADL, MSTR In Focus
Eurasia Business News
·
saa 4 zilizopita
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
ChartMill
·
saa 9 zilizopita
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
Traders Union
·
saa 6 zilizopita
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Wasifu
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Kuhusu Orexo AB
Afisa Mkuu Mtendaji (CEO)Nikolaj Sørensen
Wafanyakazi55
Lilianzishwa1995
Makao makuu-
SektaHealth Care
Sekta-
Tovutiorexo.com